GERN Geron Corporation

2.16
-0.02  -1%
Previous Close 2.18
Open 2.17
Price To book 3.04
Market Cap 343901393
Shares 159,213,608
Volume 527,244
Short Ratio 25.59
Av. Daily Volume 1,089,850

SEC filingsSee all SEC filings

  1. 8-K - Current report 171097773
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171018154
  3. 8-K - Current report 171017967
  4. 8-K - Current report 17994633
  5. 8-K - Current report 17978566

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Announced mid-January 2016 that Phase 2 dosing has been initiated. Internal reviews conducted September 2016 and April 2017, trial to continue as planned. Enrollment to be expanded 4Q 2017.
Imetelstat - IMerge Study
Myelodysplastic syndromes
Phase 2 clinical hold lifted Nov 2014. Phase 2 initiated September 2015. Internal review conducted September 2016. Low dose discontinued, high dose enrollment suspended. Further internal data review due 1Q 2018.
Imetelstat - IMbarkStudy
Myelofibrosis

Latest News

  1. ETFs with exposure to Geron Corp. : September 19, 2017
  2. Geron to Present at the Cantor Fitzgerald Healthcare Conference
  3. Geron Corp. :GERN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
  4. The Key Reason Incyte Corporation Added $850 Million in Market Cap in August
  5. Today's Research Reports on Trending Tickers: Geron Corporation and Westport Fuel Systems Inc.
  6. 3 Top Stocks Under $5
  7. 3 Top Biotech Stocks Under $5
  8. Geron's (GERN) Imetelstat Progressing Well, Setbacks Concern
  9. Geron (GERN) Q2 Loss Narrows, Sales Miss Estimates, Stock Up
  10. Geron reports 2Q loss
  11. Geron Corporation Reports Second Quarter 2017 Financial Results
  12. Geron Corp. – Value Analysis (NASDAQ:GERN) : August 4, 2017
  13. ETFs with exposure to Geron Corp. : August 4, 2017
  14. Here's Why Geron Corporation Fell as Much as 16.6% Today
  15. Tuesday’s Movers: Shopify Inc (US) (SHOP) Soars, Houston American Energy Corporation (HUSA) Skyrockets, Geron Corporation (GERN) Sinks
  16. Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : August 1, 2017
  17. Geron Announces Updates to Imetelstat Clinical Development
  18. 3 Stocks Under $5 That Could Make You Rich
  19. Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : July 21, 2017
  20. 3 Healthcare Stocks for Ambitious Investors

SEC Filings

  1. 8-K - Current report 171097773
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171018154
  3. 8-K - Current report 171017967
  4. 8-K - Current report 17994633
  5. 8-K - Current report 17978566
  6. 8-K - Current report 17835480
  7. 8-K - Current report 17826505
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 17826303
  9. 8-K - Current report 17754089
  10. 8-K - Current report 17751644